Elola-Somoza F J, Bas-Villalobos M C, Pérez-Villacastín J, Macaya-Miguel C
Fundación Instituto para la Mejora de la Asistencia Sanitaria, Madrid, España.
Instituto Cardiovascular, Hospital Clínico San Carlos, Madrid, España.
Rev Clin Esp. 2021 Aug-Sep;221(7):400-403. doi: 10.1016/j.rce.2020.11.003. Epub 2020 Dec 2.
To analyze the association between public health expenditure per capita and the mortality rate due to COVID-19 in Europe and Spain.
Pearson's correlation coefficient was used to compare and contrast the mortality rate due to COVID-19 between countries and autonomous communities with higher and lower public health expenditure per capita than the mean.
No correlation between the public health expenditure per capita and the mortality rate due to COVID-19 (r: 0.3; = 0.14) was found among European countries or Spain's Autonomous Communities (r: 0.03; = 0.91). No significant differences were found when comparing the mortality rate due to COVID-19 among the public health expenditure per capita groups.
The available evidence does not support association between «low» public healthcare expenditure and the poor outcomes observed in Spain during the COVID-19 pandemic. Increased funding for the Spanish National Health System should be earmarked for structural reforms to increase its social efficiency.
分析欧洲及西班牙人均公共卫生支出与新冠疫情死亡率之间的关联。
采用皮尔逊相关系数，对人均公共卫生支出高于或低于均值的国家及自治区之间的新冠疫情死亡率进行比较和对比。
在欧洲国家或西班牙自治区中，未发现人均公共卫生支出与新冠疫情死亡率之间存在相关性（r = 0.3；p = 0.14），在人均公共卫生支出分组中比较新冠疫情死亡率时，也未发现显著差异（r = 0.03；p = 0.91）。
现有证据不支持“低”公共医疗支出与西班牙在新冠疫情大流行期间观察到的不良结果之间存在关联。应为西班牙国家卫生系统增加资金，专门用于结构改革，以提高其社会效率。
